Publication | Closed Access

Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Prognostic FactorsHematological MalignancyOncologyMedicineAdult PatientsMixed-phenotype Acute LeukemiaImmunologyHematologyPathologyAdult T-cell Leukemia-lymphomaCallg2008 ProtocolMolecular DiagnosticsCancer Research